Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)

Abstract

The significance of evaluating oncogenes, including EGFR mutations, ALK abnormalities, and PD-L1 expression has become broadly recognized with recent advances in molecular biology. It is now extremely important to investigate tumor oncogene status in each patient at the initial diagnosis. By contrast, the significance of conducting a re-biopsy in the salvage setting has not been systematically reviewed. This review reports that the significance of a re-biopsy varies depending on the clinical situation.

Original languageEnglish
Pages (from-to)41-45
Number of pages5
JournalInternational Journal of Clinical Oncology
Volume24
Issue number1
DOIs
Publication statusPublished - Jan 22 2019

Keywords

  • Lung cancer
  • Re-biopsy
  • Treatment

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice'. Together they form a unique fingerprint.

Cite this